简化心力衰竭患者护理与机器学习的胸腔声音数据
Rony Marethianto Santoso1, Wilbert Huang2, Ser Wee3
1Faculty of Medicine, University Indonesia, Jakarta 40416, Indonesia.
World journal of cardiology
|September 30, 2025
概括
机器学习分析胸腔声音以检测心力衰竭 (HF). 这种方法显示出高精度,有望更快地进行临床整合,以改善HF患者的护理.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 人工智能的人工智能
背景情况:
- 胸腔的声音,包括心脏和肺部的声音,提供了重要的诊断信息,特别是在心力衰竭 (HF).
- 人类的听觉能力有限,无法从这些声音中提取全面的数据.
- 人工智能 (AI) 和机器学习 (ML) 为胸部声音数据提供了先进的分析能力.
研究的目的:
- 审查使用机器学习分析心力衰竭患者胸腔声音的研究.
- 总结各种ML模型,特征提取技术和现有研究中使用的分类方法.
- 评估ML在区分正常患者和HF患者以及风险分层方面的潜力.
主要方法:
- 数据预处理:对声音数据进行无声化,重新采样,细分和规范化.
- 特性提取和选择以识别相关的声学标记.
- 应用各种机器学习分类器进行分析和预测.
- 对模型性能进行分类,风险分层和预后评估的评估.
主要成果:
- 研究主要集中在心脏声音分析上,以区分正常和HF患者.
- 一些研究利用整个胸部声音进行HF分类.
- ML模型在各种高频相关分析中显示出有希望的高准确性,包括风险分层.
结论:
- 对胸腔声音的机器学习分析是心力衰竭管理的高度准确的方法.
- 该审查强调了ML模型将被整合到HF患者护理的临床实践中的潜力.
- 建议进行进一步的前性研究,以加快在日常临床工作流程中采用这些人工智能驱动工具.
更多相关视频
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
434
04:04Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
930
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
321
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
321
Heart Sounds
3.2K
Heart sounds are generated by the turbulence in blood flow due to the closing of heart valves. These sounds are best perceived slightly away from the valves, where the blood flow disseminates the sound.
Auscultation is the process of listening to these internal body sounds using a stethoscope. The heart produces four types of sounds, but only two—S1 and S2—can usually be heard with a stethoscope.
S1, also known as the "lub" sound, is caused by the closure of atrioventricular (A-V)...
Auscultation is the process of listening to these internal body sounds using a stethoscope. The heart produces four types of sounds, but only two—S1 and S2—can usually be heard with a stethoscope.
S1, also known as the "lub" sound, is caused by the closure of atrioventricular (A-V)...
3.2K
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Heart Failure I: Introduction
707
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
707
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
